Author

Steve Wade

Institution: Celgene (United States)

Observed institution: Celgene (United States)

OpenAlex ID: A5089845858

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

2021 · Grzegorz S. Nowakowski, Annalisa Chiappella, et al. · Journal of Clinical Oncology · 275

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies

2019 · Grzegorz Nowakowski, Annalisa Chiappella, et al. · Blood · 6

Works count: 2

Citation count: 281

H-index: 2

I10-index: 1